GNTA Stock Analysis: Buy, Sell, or Hold?
GNTA - Genenta Science S.p.A. American Depositary Shares
$1.01
0.02 (2.39%)
▲
5d:
-22.31%
30d:
-32.21%
90d:
-64.81%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Get Alerted When GNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GNTA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GNTA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GNTA is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.31 to $1.48.
Technical Outlook: Technically, GNTA is in a downtrend. Immediate support is located at $0.98, while resistance sits at $1.70.
Market Sentiment: GNTA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.11 (+620.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GNTA is in a downtrend. Immediate support is located at $0.98, while resistance sits at $1.70.
Market Sentiment: GNTA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.11 (+620.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.31 -
$1.48
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 620.8% below Wall St target ($7.11)
- CAUTION: 5-day price weakness (-22.3%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.31 -
$1.48
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.98
Resistance Level
$1.70
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.14
Wall Street Target
$7.11
(+620.8%)
Last updated: February 02, 2026 2:33 PM ET
Data refreshes hourly during market hours. Next update: 3:33 PM
Data refreshes hourly during market hours. Next update: 3:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 48 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
